Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Shares Outstanding (Weighted Average) (2017 - 2020)

enVVeno Medical has reported Shares Outstanding (Weighted Average) over the past 4 years, most recently at $1.4 million for Q3 2020.

  • Quarterly results put Shares Outstanding (Weighted Average) at $1.4 million for Q3 2020, down 90.38% from a year ago — trailing twelve months through Sep 2020 was $1.4 million (down 90.38% YoY), and the annual figure for FY2019 was $630418.0, down 93.27%.
  • Shares Outstanding (Weighted Average) for Q3 2020 was $1.4 million at enVVeno Medical, up from $797875.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for NVNO hit a ceiling of $15.0 million in Q3 2019 and a floor of $630418.0 in Q4 2019.
  • Median Shares Outstanding (Weighted Average) over the past 4 years was $6.1 million (2017), compared with a mean of $7.1 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 100.0% in 2019 and later plummeted 94.62% in 2020.
  • enVVeno Medical's Shares Outstanding (Weighted Average) stood at $6.1 million in 2017, then skyrocketed by 52.81% to $9.4 million in 2018, then crashed by 93.27% to $630418.0 in 2019, then skyrocketed by 129.34% to $1.4 million in 2020.
  • The last three reported values for Shares Outstanding (Weighted Average) were $1.4 million (Q3 2020), $797875.0 (Q2 2020), and $737275.0 (Q1 2020) per Business Quant data.